Concepedia
Publication | Closed Access
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia
46
Citations
0
References
2009
Year
clinicaltrials.gov Identifier: NCT00161031.